Information Disclosure - Imexpharm - Page 16

Information Disclosure

IMP – Disclosure: Report on changes in ownership of major shareholders (KBA)

07/26/2022

IMP – Information disclosure: Report on changes in related persons of internal people

07/26/2022

IMP – Information disclosure: Stock transaction report of Ms. Tran Thi Dao - General Director

07/19/2022

IMP – Information disclosure: Announcement of stock transactions of Ms. Tran Thi Dao General Director

07/13/2022

IMP – Disclosure: Announcing the audit contract with PwC Vietnam Co., Ltd

06/17/2022

IMP – BOD Resolution No. 06/NQ-HĐQT-IMP dated June 8, 2022

06/08/2022

IMP-CBTT: List of State shareholders, Strategic shareholders, Major shareholders and Treasury shares

06/01/2022

IMP - BOD Resolution No. 05/NQ-HĐQT-IMP dated May 24, 2022

05/25/2022

IMP: No. 201 – Notice of personnel changes (members of the Board of Directors)

05/25/2022

IMP - Disclosure: Explanation of transactions on March 30, 2022

05/18/2022